Delivery Order SPE2DB22D2005-SPE2DB23FJMU3
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $4,012.26 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of ELURYNG VAGINAL RINGS. This delivery order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract does not have a set-aside designation, indicating open...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of medical products such as Eluryng vaginal rings. The contract, valued at $2,015.40, has a completion date of March 14, 2022. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans...
- This federal contract award, valued at $1,178.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of ELURYNG VAGINAL RINGS, a pharmaceutical product. The contract has a completion date of September 13, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,491.22 firm-fixed-price delivery order is for the supply of ELURYNG vaginal rings, with a completion date of February 9, 2022. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,899.20 to AmerisourceBergen Drug Corp for the supply of eluryng vaginal rings. This firm fixed-price delivery order, which was not set-aside, is scheduled for completion by January 28, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,046.80 firm fixed price delivery order contract is for the supply of ELURYNG VAGINAL RINGS, with a period of performance through March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- On January 29, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,151.33 to Amerisourcebergen Drug Corp for the supply of eluryng vaginal rings. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 30, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB21FU08M) valued at $3,148.12 for the supply of "ELURYNG VAGINAL RINGS." The contract was awarded by the Defense Logistics Agency (DLA) on September 27, 2021, with a completion date of September 28, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of 4556447022 ELURYNG vaginal rings to the Defense Logistics Agency (DLA). The $2,208.75 firm fixed price contract was awarded on March 3, 2022 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- The Defense Logistics Agency awarded a delivery order valued at $2,498.22 to AmerisourceBergen Drug Corp for eluryng vaginal rings on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The contract carries no set-aside...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB23FJMU3Delivery Order
The Defense Logistics Agency (DLA) awarded a $5,846.96 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of ELURYNG VAGINAL RINGS. This contract has an ultimate completion date of April 12, 2023 and was not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier of medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which acts as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 4/11/23 |